Free Trial

Curaleaf (OTCMKTS:CURLF) Shares Gap Down - What's Next?

Curaleaf logo with Medical background

Key Points

  • Curaleaf's share price gapped down from $3.30 to $3.00 before trading, with a last trade at $3.09 and a trading volume of 342,619 shares.
  • Cormark upgraded Curaleaf from a "hold" to a "moderate buy" rating, and the stock has a consensus rating of "Strong Buy" among analysts.
  • In its recent quarterly earnings, Curaleaf reported a loss of ($0.06) earnings per share, beating expectations, but maintained a negative net margin of 18.08% and an anticipated annual loss of -0.25 EPS.
  • Five stocks to consider instead of Curaleaf.

Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report)'s stock price gapped down before the market opened on Tuesday . The stock had previously closed at $3.30, but opened at $3.00. Curaleaf shares last traded at $3.09, with a volume of 342,619 shares traded.

Wall Street Analysts Forecast Growth

Separately, Cormark upgraded Curaleaf from a "hold" rating to a "moderate buy" rating in a research report on Friday, August 8th. One analyst has rated the stock with a Strong Buy rating, According to MarketBeat, the company has an average rating of "Strong Buy".

View Our Latest Report on CURLF

Curaleaf Trading Up 1.8%

The firm has a 50-day moving average of $1.91 and a 200 day moving average of $1.26. The company has a market cap of $1.91 billion, a P/E ratio of -8.91 and a beta of 0.78. The company has a current ratio of 1.47, a quick ratio of 0.70 and a debt-to-equity ratio of 1.00.

Curaleaf (OTCMKTS:CURLF - Get Free Report) last released its quarterly earnings data on Wednesday, August 6th. The company reported ($0.06) earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.01. Curaleaf had a negative net margin of 18.08% and a negative return on equity of 14.61%. On average, analysts predict that Curaleaf Holdings, Inc. will post -0.25 earnings per share for the current fiscal year.

Curaleaf Company Profile

(Get Free Report)

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.

See Also

Should You Invest $1,000 in Curaleaf Right Now?

Before you consider Curaleaf, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.

While Curaleaf currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.